Yüklüyor......
Glypican-3 antibodies: a new therapeutic target for liver cancer
Glypican-3 (GPC3) is an emerging therapeutic target in hepatocellular carcinoma (HCC), even though the biological function of GPC3 remains elusive. Currently human (MDX-1414 and HN3) and humanized mouse (GC33 and YP7) antibodies that target GPC3 for HCC treatment are under different stages of precli...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3947105/ https://ncbi.nlm.nih.gov/pubmed/24140348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.febslet.2013.10.002 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|